Skip to main content

Medican Enterprises CEO Kenneth Williams Updates Shareholders

Medican Enterprises, Inc. (OTCQB:MDCN) announces that it is in the process of relocating the corporate offices to Ypsilanti, Michigan, a city that Medican CEO, Kenneth Williams knows very well. According to Mr. Williams, “We believe there are opportunities here that offer Medican Enterprises excellent opportunities to offer our products and services in a state that has laws very favorable to the medical marijuana industry.”

For this move to Michigan, we plan to purchase a building in Ypsilanti that is already zoned appropriately for our business. We will update investors as we move forward on this. In the location we have chosen we plan to create a wellness center that will operate as a dispensary and will have a wellness center for professionals to consult with their patients. “We are very excited about closing on this project. We believe we will be closing shortly and the possibilities to extend our brand in Michigan are tremendous”, stated Mr. Williams.

After careful consideration the company has determined that it is in the company’s best interest to focus current expansion plans in Michigan. According to Mr. Williams, “We determined that we needed to concentrate in a market we know well where we will have the greatest chances for immediate success. Of course, we remain active in other areas as well. We are simply very enthused about Michigan, given my personal familiarity, the favorable regulatory climate, and the lack of high profile competition that exists in other states more widely known as being friendly to our industry.”

About Medican Enterprises, Inc.

Medican Enterprises is a bio-pharmaceutical company focused on pursuing business opportunities in the growing medical and recreational marijuana sector. Through its subsidiaries, Medican is seeking to invest in our businesses associated with the growing, marketing, research and development, training, distribution and retail sale of medical and recreational marijuana, both in the United States and Canada. For more information visit: http://Medican.Enterprises.

Cautionary Note Regarding Forward-Looking Statements

This press release and statements of representatives of Medican Enterprises, Inc. (the “Company”) related thereto includes forward-looking statements within the meaning of the U.S. federal securities laws. Forward looking statements are statements that are not historical facts. Such forward-looking statements are subject to significant risks and uncertainties that are subject to change based on various factors (many of which are beyond the Company's control), which could cause actual results to differ from the forward looking statements.Such statements may include, without limitation, statements with respect to the Company's plans, objectives, projections, expectations and intentions and other statements identified by words such as "projects," "may," "will," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," "potential" or similar expressions. These statements are based upon the current beliefs and expectations of the Company's management but are subject to significant risks and uncertainties, including those detailed in the Company's filings with the Securities and Exchange Commission.Actual results (including, without limitation, the results of the Company’s efforts to acquire and integrate Future Harvest as described herein) may differ from those set forth in the forward-looking statements. Except as required by applicable law, the Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Contacts:

Medican Enterprises Inc.
Ken Williams, 800-416-8802
CEO
investors@medican.enterprises

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.